2m 2m 2m 2m 2m 2m 2m
CRONOS GROUP (CRON)
NASDAQ
$2.71-$0.02 (-0.92%)
Price as of Jun 03, 2026 7:11 PM EDT- $1.1BMarket Cap
- 41.45%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CRONOS GROUP (CRON)
$2.71-$0.02 (-0.92%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 146.6M +24.63% | 117.6M +34.82% | 87.2M -5.07% | 91.9M +23.47% | |
Cost of Revenue | 11.4M 0.00% | 11.4M N/A | N/A N/A | N/A N/A | |
Gross Profit | 62.8M +149.06% | 25.2M +111.59% | 11.9M -0.50% | 12.0M +168.26% | |
Sales and Marketing Expense | 21.8M +0.75% | 21.6M -4.84% | 22.7M +1.88% | 22.3M -50.42% | |
Research and Development Expense | -4.4M +5.20% | -4.2M -27.62% | -5.8M -56.33% | -13.4M -42.65% | |
Depreciation and Amortization Expense | 14.2M +52.43% | 9.3M +15.12% | 8.1M -38.20% | 13.1M -14.80% | |
Total Operating Expenses | 80.2M -21.21% | 101.7M +5.19% | 96.7M -29.31% | 136.8M -74.81% | |
Operating Profit | -17.4M -77.27% | -76.5M -9.75% | -84.8M -32.07% | -124.8M -77.73% | |
Interest Income | -446,000 -88.39% | -3.8M -63.46% | -10.5M -158.89% | 17.9M +96.23% | |
Interest Expense | N/A N/A | 0 N/A | N/A N/A | 0 N/A | |
Interest Income and Expense and Net | -446,000 -88.39% | -3.8M -63.46% | -10.5M -158.89% | 17.9M +96.23% | |
Total Nonoperating Income and Expense | 275,000 -99.76% | 113.1M +916.22% | 11.1M +214.50% | -9.7M -105.95% | |
Income before Taxes | -17.1M -146.79% | 36.6M +149.66% | -73.7M -45.25% | -134.6M -66.12% | |
Income Taxes | -14.2M +313.01% | -3.4M +6.38% | -3.2M -109.45% | 34.2M +8,029.23% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -9.4M -123.00% | 41.1M +155.54% | -74.0M -56.17% | -168.7M -57.40% | |
Net Income from Continuing Operations Applicable to Common | -17.1M -146.79% | 36.6M +149.66% | -73.7M -45.25% | -134.6M -66.12% | |
Basic EPS and Net Income | -0.02 -118.18% | 0.11 +157.89% | -0.19 N/A | N/A N/A | |
Diluted EPS and Net Income | -0.02 -118.18% | 0.11 +157.89% | -0.19 N/A | N/A N/A | |
Basic Weighted Average Shares | 383.5M +0.37% | 382.1M +0.29% | 381.0M +1.06% | 377.0M +1.77% | |
Diluted Weighted Average Shares | 383.5M -0.54% | 385.6M +1.21% | 381.0M +1.06% | 377.0M +1.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 791.8M -7.80% | 858.8M +28.32% | 669.3M -12.47% | 764.6M -13.79% | |
Short-Term Investments | 40.0M N/A | 0 -100.00% | 192.2M +70.01% | 113.1M -3.91% | |
Cash and Cash Equivalents and Short-Term Investments | 831.8M -3.15% | 858.8M -0.32% | 861.5M -1.84% | 877.7M -12.63% | |
Total Current Assets | 944.1M +0.85% | 936.1M +0.30% | 933.3M -2.80% | 960.2M -11.07% | |
Accumulated Depreciation | 42.6M +43.09% | 29.8M -2.96% | 30.7M -13.13% | 35.3M +16.63% | |
Property and Plant and Equipment and Net | 145.9M +9.52% | 133.2M +123.97% | 59.5M -1.80% | 60.6M -18.24% | |
Total Long-Term Assets | 145.9M +9.52% | 133.2M +295,875.56% | 45,000 -76.68% | 193,000 +93.00% | |
Total Assets | 1.2B +2.64% | 1.2B +2.30% | 1.1B -6.01% | 1.2B -13.22% | |
Income Taxes Payable | 4.1M +14.44% | 3.6M +5,482.81% | 64,000 -99.81% | 33.0M +40,586.42% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 384,000 N/A | |
Total Current Liabilities | 48.2M -3.04% | 49.7M +20.05% | 41.4M -39.22% | 68.1M +25.28% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 1.5M +8.46% | 1.4M -27.71% | |
Total Long-Term Liabilities | 733,000 -31.69% | 1.1M +6.98% | 1.0M -60.60% | 2.5M -64.92% | |
Total Liabilities | 54.2M -2.08% | 55.3M +25.86% | 44.0M -38.98% | 72.0M +13.52% | |
Retained Earnings | 447.8M -2.17% | 457.7M +9.84% | 416.7M -15.07% | 490.7M -25.59% | |
Total Stockholders Equity | 1.1B +2.80% | 1.1B -3.23% | 1.1B -3.87% | 1.1B -14.46% | |
Total Shares Outstanding | 381.6M -0.25% | 382.5M +0.32% | 381.3M +0.19% | 380.6M +1.50% | |
Cash Flow | |||||
Cash from Operating Activities | 25.9M +37.27% | 18.8M +143.99% | -42.8M -51.84% | -88.9M -42.10% | |
Capital Expenditures | 25.7M +107.21% | 12.4M +395.45% | 2.5M -27.41% | 3.5M -69.03% | |
Cash from Investing Activities | -76.6M -143.71% | 175.1M +394.37% | -59.5M +3,130.13% | -1.8M -93.63% | |
Dividends Paid | 6.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -19.9M +1,516.98% | -1.2M +19.51% | -1.0M -64.45% | -2.9M -78.45% | |
Financials Ratio | |||||
Gross Margin | 92.23% +2.12% | 90.32% N/A | N/A N/A | N/A N/A | |
Operating Margin | -11.87% -81.76% | -65.07% -33.06% | -97.20% -28.44% | -135.84% -81.96% | |
Return on Assets | -0.80% -122.44% | 3.56% +156.67% | -6.29% -51.37% | -12.93% -45.77% | |
Return on Equity | -0.88% -123.06% | 3.80% +157.59% | -6.59% -51.52% | -13.60% -47.66% | |
Revenue Growth | 24.63% -29.25% | 34.82% +786.20% | -5.07% -121.62% | 23.47% -60.44% | |
Current Ratio | 19.59 +4.02% | 18.84 -16.45% | 22.54 +59.93% | 14.10 -29.02% | |
Cash Ratio | 16.43 -4.91% | 17.28 +6.88% | 16.17 +44.02% | 11.23 -31.18% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.002 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.002 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow